 <h1>Betacort Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>betamethasone topical</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about betamethasone topical. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Betacort.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to betamethasone topical: topical application cream, topical application lotion, topical application ointment, topical application spray</i></p><p>Other dosage forms:</p><ul><li>topical application cream, topical application foam, topical application lotion, topical application ointment</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, betamethasone topical (the active ingredient contained in Betacort) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking betamethasone topical:</p><p>
<i>More common</i>
</p><ul>
<li>Burning or stinging</li>
<li>itching at the application site</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blistering, burning, crusting, dryness, or flaking of the skin</li>
<li>cracking or tightening of the skin</li>
<li>dry skin</li>
<li>flushing or redness of the skin</li>
<li>irritation</li>
<li>itching, scaling, severe redness, soreness, or swelling of the skin</li>
<li>thinning of the skin with easy bruising, especially when used on the face or where the skin folds together (eg, between the fingers)</li>
<li>unusually warm skin</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blindness</li>
<li>blurred vision</li>
<li>change in vision</li>
<li>decreased vision</li>
<li>eye pain</li>
<li>headache</li>
<li>loss of vision</li>
<li>nausea</li>
<li>redness and scaling around the mouth</li>
<li>tearing</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of betamethasone topical may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Raised, dark red, or wart-like spots on the skin, especially when used on the face</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Burning, itching, and pain in hairy areas, or pus at the root of the hair</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Acne or pimples</li>
<li>burning and itching of the skin with pinhead-sized red blisters</li>
<li>increased hair growth on the forehead, back, arms, and legs</li>
<li>lightening of normal skin color</li>
<li>lightening of treated areas of dark skin</li>
<li>reddish purple lines on the arms, face, legs, trunk, or groin</li>
<li>softening of the skin</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to betamethasone topical: topical cream, topical foam, topical gel, topical lotion, topical ointment, topical spray</i></p><h3>General</h3><p>The most commonly reported side effects were pruritus, burning, itching, irritation.</p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity</p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Cushing's syndrome<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Folliculitis, skin infections (including bacterial, fungal and viral skin infections)</p>
<p><b>Frequency not reported</b>: Dryness, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae, miliaria<sup>[Ref]</sup></p><h3>Local</h3><p><b>Uncommon</b> (0.1% to 1%): Application site pain</p>
<p><b>Frequency not reported</b>: Burning, itching, irritation<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Eye disorder</p>
<p><b>Postmarketing reports</b>: cataracts, glaucoma, increased intraocular pressure, central serous chorioretinopathy<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Hyperglycemia</p><h3>Renal</h3><p><b>Frequency not reported</b>: Glucosuria</p><h3>Other</h3><p><b>Rare</b> (less than 0.1%): Rebound effect</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Ruiz-Maldonado R, Zapata G, Lourdes T, Robles C "Cushing's syndrome after topical application of corticosteroids." Am J Dis Child 136 (1982): 274-5</p><p id="ref_2">2. Flynn MD, Beasley P, Tooke JE "Adrenal suppression with intranasal betamethasone drops." J Laryngol Otol 106 (1992): 827-8</p><p id="ref_3">3. Stoppoloni G, Prisco F, Santinelli R, Sicuranza G, Giordano C "Potential hazards of topical steroid therapy." Am J Dis Child 137 (1983): 1130-1</p><p id="ref_4">4. Walsh P, Aeling JL, Huff L, Weston WL "Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids." J Am Acad Dermatol 29 (1993): 501-3</p><p id="ref_5">5. Salde L, Lassus A "Systemic side-effects of three topical steroids in diseased skin." Curr Med Res Opin 8 (1983): 475-80</p><p id="ref_6">6. Reymann F, Kehlet H "Hypothalamic-pituitary-adrenocortical function. Association with topical application of betamethasone dipropionate." Arch Dermatol 115 (1979): 362-3</p><p id="ref_7">7. Cunliffe WJ, Burton JL, Holti G, Wright V "Hazards of steroid therapy in hepatic failure." Br J Dermatol 93 (1975): 183-5</p><p id="ref_8">8. "Product Information. Diprolene (betamethasone topical)." Schering Laboratories, Kenilworth, NJ. </p><p id="ref_9">9. Stevens DJ "Cushing's syndrome due to the abuse of betamethasone nasal drops." J Laryngol Otol 102 (1988): 219-21</p><p id="ref_10">10. Macdonald A "Topical corticosteroid preparations. Hazards and side-effects." Br J Clin Pract 25 (1971): 421-5</p><p id="ref_11">11. Grice K "Tinea of the hand and forearm. Betamethasone valerate atrophy." Proc R Soc Med 59 (1966): 254-5</p><p id="ref_12">12. Ellis CN, Katz HI, Rex IH Jr, Shavin JS, Van Scott EJ, VanderPloeg D "A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis." Clin Ther 11 (1989): 768-74</p><p id="ref_13">13. Barkey WF "Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream)." J Am Acad Dermatol 17 (1987): 518-9</p><p id="ref_14">14. Sneddon I "Perioral dermatitis." Br J Dermatol 87 (1972): 430-4</p><p id="ref_15">15. Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J, et al "Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis." J Am Acad Dermatol 26 (1992): 125-7</p><p id="ref_16">16. Hellgren L "Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis." Ann Clin Res 8 (1976): 317-9</p><p id="ref_17">17. Butcher JM, Austin M, McGalliard J, Bourke RD "Bilateral cataracts and glaucoma induced by long term use of steroid eye drops." BMJ 309 (1994): 43</p><p id="ref_18">18. Kitazawa Y "Increased intraocular pressure induced by corticosteroids." Am J Ophthalmol 82 (1976): 492-5</p><p id="ref_19">19. Eisenlohr JE "Glaucoma following the prolonged use of topical steroid medication to the eyelids." J Am Acad Dermatol 8 (1983): 878-81</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Betacort (betamethasone topical)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: topical steroids</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Diprolene, Diprosone, Valisone, Betnovate, ... +6 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Atopic Dermatitis</li>
<li>Dermatitis</li>
<li>Dermatological Disorders</li>
<li>Lichen Planus</li>
<li>Lichen Sclerosus</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to betamethasone topical: topical cream, topical foam, topical gel, topical lotion, topical ointment, topical spray</i></p><h3>General</h3><p>The most commonly reported side effects were pruritus, burning, itching, irritation.</p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Hypersensitivity</p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Cushing's syndrome<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Folliculitis, skin infections (including bacterial, fungal and viral skin infections)</p><p><b>Frequency not reported</b>: Dryness, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae, miliaria<sup>[Ref]</sup></p><h3>Local</h3><p><b>Uncommon</b> (0.1% to 1%): Application site pain</p><p><b>Frequency not reported</b>: Burning, itching, irritation<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Eye disorder</p><p><b>Postmarketing reports</b>: cataracts, glaucoma, increased intraocular pressure, central serous chorioretinopathy<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Hyperglycemia</p><h3>Renal</h3><p><b>Frequency not reported</b>: Glucosuria</p><h3>Other</h3><p><b>Rare</b> (less than 0.1%): Rebound effect</p><p id="ref_1">1. Ruiz-Maldonado R, Zapata G, Lourdes T, Robles C "Cushing's syndrome after topical application of corticosteroids." Am J Dis Child 136 (1982): 274-5</p><p id="ref_2">2. Flynn MD, Beasley P, Tooke JE "Adrenal suppression with intranasal betamethasone drops." J Laryngol Otol 106 (1992): 827-8</p><p id="ref_3">3. Stoppoloni G, Prisco F, Santinelli R, Sicuranza G, Giordano C "Potential hazards of topical steroid therapy." Am J Dis Child 137 (1983): 1130-1</p><p id="ref_4">4. Walsh P, Aeling JL, Huff L, Weston WL "Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids." J Am Acad Dermatol 29 (1993): 501-3</p><p id="ref_5">5. Salde L, Lassus A "Systemic side-effects of three topical steroids in diseased skin." Curr Med Res Opin 8 (1983): 475-80</p><p id="ref_6">6. Reymann F, Kehlet H "Hypothalamic-pituitary-adrenocortical function. Association with topical application of betamethasone dipropionate." Arch Dermatol 115 (1979): 362-3</p><p id="ref_7">7. Cunliffe WJ, Burton JL, Holti G, Wright V "Hazards of steroid therapy in hepatic failure." Br J Dermatol 93 (1975): 183-5</p><p id="ref_8">8. "Product Information. Diprolene (betamethasone topical)." Schering Laboratories, Kenilworth, NJ. </p><p id="ref_9">9. Stevens DJ "Cushing's syndrome due to the abuse of betamethasone nasal drops." J Laryngol Otol 102 (1988): 219-21</p><p id="ref_10">10. Macdonald A "Topical corticosteroid preparations. Hazards and side-effects." Br J Clin Pract 25 (1971): 421-5</p><p id="ref_11">11. Grice K "Tinea of the hand and forearm. Betamethasone valerate atrophy." Proc R Soc Med 59 (1966): 254-5</p><p id="ref_12">12. Ellis CN, Katz HI, Rex IH Jr, Shavin JS, Van Scott EJ, VanderPloeg D "A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis." Clin Ther 11 (1989): 768-74</p><p id="ref_13">13. Barkey WF "Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream)." J Am Acad Dermatol 17 (1987): 518-9</p><p id="ref_14">14. Sneddon I "Perioral dermatitis." Br J Dermatol 87 (1972): 430-4</p><p id="ref_15">15. Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J, et al "Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis." J Am Acad Dermatol 26 (1992): 125-7</p><p id="ref_16">16. Hellgren L "Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis." Ann Clin Res 8 (1976): 317-9</p><p id="ref_17">17. Butcher JM, Austin M, McGalliard J, Bourke RD "Bilateral cataracts and glaucoma induced by long term use of steroid eye drops." BMJ 309 (1994): 43</p><p id="ref_18">18. Kitazawa Y "Increased intraocular pressure induced by corticosteroids." Am J Ophthalmol 82 (1976): 492-5</p><p id="ref_19">19. Eisenlohr JE "Glaucoma following the prolonged use of topical steroid medication to the eyelids." J Am Acad Dermatol 8 (1983): 878-81</p><h2>More about Betacort (betamethasone topical)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: topical steroids</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Atopic Dermatitis</li>
<li>Dermatitis</li>
<li>Dermatological Disorders</li>
<li>Lichen Planus</li>
<li>Lichen Sclerosus</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>